BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹16,493 Cr | ₹15,120 Cr | ₹20,742 Cr | ₹6,803 Cr | ₹5,497 Cr |
What is the latest Total Non-Current Liabilities ratio of BIOCON ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹16,493 Cr |
| Mar2024 | ₹15,120 Cr |
| Mar2023 | ₹20,742 Cr |
| Mar2022 | ₹6,803 Cr |
| Mar2021 | ₹5,497 Cr |
How is Total Non-Current Liabilities of BIOCON Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16,493 Cr | 9.08 | |
| Mar2024 | ₹15,120 Cr | -27.11 | |
| Mar2023 | ₹20,742 Cr | 204.91 | |
| Mar2022 | ₹6,803 Cr | 23.76 | |
| Mar2021 | ₹5,497 Cr | - | |
Compare Total Non-Current Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹59,705.9 Cr | -3.9% | -2.9% | 18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -3.9% |
-2.9% |
18.4% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses